Bayesian Capital Management LP acquired a new position in Cognex Co. (NASDAQ:CGNX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 14,400 shares of the scientific and technical instruments company's stock, valued at approximately $516,000.
Other large investors also recently modified their holdings of the company. BNP Paribas Financial Markets lifted its stake in Cognex by 28.9% during the 4th quarter. BNP Paribas Financial Markets now owns 95,816 shares of the scientific and technical instruments company's stock valued at $3,436,000 after acquiring an additional 21,455 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in Cognex by 62.2% during the fourth quarter. Ameriprise Financial Inc. now owns 1,475,379 shares of the scientific and technical instruments company's stock worth $52,907,000 after purchasing an additional 566,047 shares during the last quarter. Algert Global LLC bought a new stake in Cognex in the 4th quarter worth about $2,933,000. Jane Street Group LLC increased its stake in Cognex by 8.1% in the 4th quarter. Jane Street Group LLC now owns 75,724 shares of the scientific and technical instruments company's stock valued at $2,715,000 after buying an additional 5,696 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of Cognex by 139.7% during the 4th quarter. AQR Capital Management LLC now owns 1,096,710 shares of the scientific and technical instruments company's stock worth $39,328,000 after buying an additional 639,258 shares in the last quarter. Institutional investors own 88.12% of the company's stock.
Insiders Place Their Bets
In other news, EVP Carl Gerst sold 6,803 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $32.73, for a total value of $222,662.19. Following the transaction, the executive vice president now owns 4,566 shares of the company's stock, valued at $149,445.18. This represents a 59.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.60% of the company's stock.
Cognex Price Performance
Shares of CGNX traded up $0.05 during midday trading on Friday, hitting $29.47. 2,988,050 shares of the company traded hands, compared to its average volume of 1,543,543. Cognex Co. has a one year low of $22.67 and a one year high of $53.13. The firm has a market cap of $4.95 billion, a P/E ratio of 48.31 and a beta of 1.45. The stock has a 50-day moving average of $28.13 and a 200-day moving average of $34.59.
Cognex (NASDAQ:CGNX - Get Free Report) last posted its earnings results on Wednesday, February 12th. The scientific and technical instruments company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Cognex had a return on equity of 5.65% and a net margin of 11.61%. Sell-side analysts forecast that Cognex Co. will post 0.61 EPS for the current fiscal year.
Cognex Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, May 15th will be given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend is Thursday, May 15th. Cognex's payout ratio is 47.06%.
Analyst Ratings Changes
A number of brokerages recently commented on CGNX. DA Davidson decreased their price target on Cognex from $35.00 to $32.00 and set a "neutral" rating for the company in a research report on Monday, May 5th. Cowen upgraded Cognex from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. UBS Group cut their price target on shares of Cognex from $56.00 to $53.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Needham & Company LLC decreased their price objective on shares of Cognex from $41.00 to $33.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Finally, HSBC cut shares of Cognex from a "buy" rating to a "hold" rating and set a $33.00 target price on the stock. in a research note on Friday, February 21st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Cognex currently has a consensus rating of "Hold" and an average price target of $39.17.
Get Our Latest Stock Analysis on Cognex
Cognex Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Stories
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
